Alkem’s Bioequivalence center is an independent Clinical Research Organization with global standards.

Alkem Bioequivalence center is a state of the art facility with 112 beds, in house Emergency care unit and well equipped bio-analytical laboratory. This centre conduct bioequivalence and bioavailability studies on healthy volunteers to prove the safety and effectiveness of developed formulations for various regulatory agencies world-wide. The testimony of being global standards is, this facility has faced and successfully cleared multiple inspections by DCGI, USFDA, UK-MHRA, NPRA (Malaysian agency), ISP- Chile; which are some of the world-wide stringent regulatory bodies. Thus, Alkem has received many product approvals from various regulatory bodies of different countries, after successful completion of bioequivalence studies on its formulations.